MX2009004682A - Uso de dmae para el tratamiento de deficit cognitivo ligero. - Google Patents
Uso de dmae para el tratamiento de deficit cognitivo ligero.Info
- Publication number
- MX2009004682A MX2009004682A MX2009004682A MX2009004682A MX2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A MX 2009004682 A MX2009004682 A MX 2009004682A
- Authority
- MX
- Mexico
- Prior art keywords
- dmae
- treatment
- cognitive impairment
- mild cognitive
- sole agent
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 208000027061 mild cognitive impairment Diseases 0.000 title abstract 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 abstract 2
- 229960002887 deanol Drugs 0.000 abstract 2
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000000971 hippocampal effect Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0609548A FR2907679B1 (fr) | 2006-10-31 | 2006-10-31 | Utilisation de dmae pour le traitement de deficit cognitif leger |
| PCT/EP2007/061737 WO2008053011A1 (fr) | 2006-10-31 | 2007-10-31 | Le dmae en tant qu'agent unique pour le traitement de deficit cognitif leger |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004682A true MX2009004682A (es) | 2009-09-28 |
Family
ID=38050144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004682A MX2009004682A (es) | 2006-10-31 | 2007-10-31 | Uso de dmae para el tratamiento de deficit cognitivo ligero. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8207218B2 (https=) |
| EP (1) | EP2083814B1 (https=) |
| JP (1) | JP2010508253A (https=) |
| KR (1) | KR20090082428A (https=) |
| CN (1) | CN101528220A (https=) |
| AR (1) | AR063764A1 (https=) |
| AU (1) | AU2007316137A1 (https=) |
| BR (1) | BRPI0718263A2 (https=) |
| CA (1) | CA2667983A1 (https=) |
| FR (1) | FR2907679B1 (https=) |
| IL (1) | IL198463A0 (https=) |
| MA (1) | MA30925B1 (https=) |
| MX (1) | MX2009004682A (https=) |
| NO (1) | NO20092099L (https=) |
| RU (1) | RU2009120137A (https=) |
| TN (1) | TN2009000159A1 (https=) |
| WO (1) | WO2008053011A1 (https=) |
| ZA (1) | ZA200903626B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150157046A1 (en) * | 2013-12-10 | 2015-06-11 | Lifewave, Inc. | Nutritional product composition for the mind |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002320251A1 (en) * | 2001-07-05 | 2003-01-21 | Vital Basics, Inc. | Compositions for improving mental performance |
| US20060211721A1 (en) * | 2005-03-21 | 2006-09-21 | Roberts Alan R | Nutraceutical formulation of a cognitive enhancement system |
-
2006
- 2006-10-31 FR FR0609548A patent/FR2907679B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-31 MX MX2009004682A patent/MX2009004682A/es not_active Application Discontinuation
- 2007-10-31 US US12/447,816 patent/US8207218B2/en not_active Expired - Fee Related
- 2007-10-31 CN CNA2007800401804A patent/CN101528220A/zh active Pending
- 2007-10-31 AU AU2007316137A patent/AU2007316137A1/en not_active Abandoned
- 2007-10-31 CA CA002667983A patent/CA2667983A1/fr not_active Abandoned
- 2007-10-31 JP JP2009533884A patent/JP2010508253A/ja not_active Withdrawn
- 2007-10-31 WO PCT/EP2007/061737 patent/WO2008053011A1/fr not_active Ceased
- 2007-10-31 EP EP07822084A patent/EP2083814B1/fr active Active
- 2007-10-31 RU RU2009120137/15A patent/RU2009120137A/ru not_active Application Discontinuation
- 2007-10-31 KR KR1020097010586A patent/KR20090082428A/ko not_active Withdrawn
- 2007-10-31 BR BRPI0718263-5A patent/BRPI0718263A2/pt not_active IP Right Cessation
- 2007-10-31 AR ARP070104851A patent/AR063764A1/es not_active Application Discontinuation
-
2009
- 2009-04-24 TN TNP2009000159A patent/TN2009000159A1/fr unknown
- 2009-04-30 IL IL198463A patent/IL198463A0/en unknown
- 2009-05-26 ZA ZA200903626A patent/ZA200903626B/xx unknown
- 2009-05-27 MA MA31926A patent/MA30925B1/fr unknown
- 2009-05-28 NO NO20092099A patent/NO20092099L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TN2009000159A1 (fr) | 2010-10-18 |
| IL198463A0 (en) | 2010-02-17 |
| CA2667983A1 (fr) | 2008-05-08 |
| EP2083814B1 (fr) | 2013-03-20 |
| JP2010508253A (ja) | 2010-03-18 |
| RU2009120137A (ru) | 2010-12-10 |
| AR063764A1 (es) | 2009-02-18 |
| US20090298908A1 (en) | 2009-12-03 |
| NO20092099L (no) | 2009-07-17 |
| MA30925B1 (fr) | 2009-11-02 |
| FR2907679B1 (fr) | 2009-10-30 |
| EP2083814A1 (fr) | 2009-08-05 |
| BRPI0718263A2 (pt) | 2014-01-07 |
| US8207218B2 (en) | 2012-06-26 |
| KR20090082428A (ko) | 2009-07-30 |
| AU2007316137A1 (en) | 2008-05-08 |
| CN101528220A (zh) | 2009-09-09 |
| ZA200903626B (en) | 2010-07-28 |
| FR2907679A1 (fr) | 2008-05-02 |
| WO2008053011A1 (fr) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
| MX2009002666A (es) | Compuestos de n-metilaminometil isoindol, composiciones que los comprenden y metodos que utilizan los mismos. | |
| TW200745078A (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| UA97795C2 (uk) | Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки | |
| MX2011012122A (es) | Derivados de tiofeno. | |
| UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
| WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
| UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
| MX2009001062A (es) | Agonistas de ep2. | |
| MX2008010035A (es) | Compuestos de n-hidroxiacrilamida. | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| WO2009032843A3 (en) | Deuterated ethambutols and their use | |
| TW200639156A (en) | New compounds | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| TW200734334A (en) | Treatment of substance abuse | |
| WO2011153458A3 (en) | Compositions and methods for inhibition of or treatment of dengue virus infection | |
| WO2008004100A3 (en) | Therapeutic compounds | |
| UA94042C2 (ru) | Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса | |
| WO2007121471A3 (en) | Dialkyl ether delivery agents | |
| TW200719903A (en) | Compositions for the treatment of neoplasms | |
| MX2009004682A (es) | Uso de dmae para el tratamiento de deficit cognitivo ligero. | |
| MX2009008813A (es) | Composicion farmaceutica que contiene floroglucinol y paracetamol. | |
| UA94953C2 (en) | Ep2 agonists | |
| MY160963A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |